Skip to main content
Equibles
CHCT logo

CHCT · Community Healthcare Trust Inc · Metrics

Track CHCT — free

Use CHCT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CHCT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.75 -0.03 (-0.23%) At close · Oct 28 Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$365.34M
Shares
28.65M
Volume · Oct 28 428.6K Avg daily vol (3M) 379K

CHCT metrics

86 of 126 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$12.75
Market cap
$365.34M

Price action

20 metrics
Price change (1W)
+0.9%
Price change (30D)
-11.4%
Price change (3M)
-32.0%
Price change (6M)
-26.1%
Price change (YTD)
-22.4%
Price change (1Y)
-11.9%
Trailing year
Price change (5Y)
-73.6%
52-week high
$19.02
52-week low
$12.64
Change from 52-week high
-33.0%
Change from 52-week low
+0.9%
Annualized volatility
27.7%
Annualized volatility (3M)
34.3%
Beta
0.1
RSI (14D)
33.9
Price vs SMA 50
-9.6%
Price vs SMA 200
-22.4%
Avg volume (3M)
379,001
Relative volume
1.1
Average dollar volume
$5.51M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
28.65M

Valuation

14 metrics
P / FFO
7.8×
Company-stated · TTM · reciprocal yield 12.8%
P / AFFO
6.2×
Company-stated · TTM · reciprocal yield 16.1%
P / E (TTM)
18.8
Trailing earnings · reciprocal yield 5.3%
PEG ratio
—
EV / revenue
7.4×
reciprocal yield 13.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
2.9×
reciprocal yield 34.2%
P / book
0.9
reciprocal yield 113.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
6.1
reciprocal yield 16.3%
Earnings yield
5.7%

Historical valuation

8 metrics
P / E historical average (3Y)
121.1×
reciprocal yield 0.8%
P / E historical average (5Y)
89.5×
reciprocal yield 1.1%
EV / revenue historical average (3Y)
9.1×
reciprocal yield 11.0%
EV / revenue historical average (5Y)
11.0×
reciprocal yield 9.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
13.8%
Trailing 12 months
Payout ratio
259.5%
Shareholder yield
14.9%
Dividend / share (TTM)
$1.76
Dividend growth YoY
-6.0%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-08-19

Earnings calendar

2 metrics
Next earnings
2026-11-04
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
16.8%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$20.98M
Trailing 12 months
Diluted EPS (TTM)
$0.68
FCF margin
—
Effective tax rate
—

Per share

13 metrics
FFO per diluted share
—
AFFO per diluted share
—
Revenue per diluted share (TTM)
$4.63
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$0.78
Operating cash flow per diluted share (TTM)
$2.21
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.39
Book value per share
$15.08

Growth

11 metrics
Revenue growth YoY
+7.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$124.78M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.8%
Year over year · more shares
Revenue CAGR (3Y)
+7.5%
Revenue CAGR (5Y)
+9.9%
EPS CAGR (3Y)
-53.8%
EPS CAGR (5Y)
-36.9%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
5.1%
Return on assets
2.1%
Debt / equity
1.4
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$556.65M
Latest balance sheet
Cash & equivalents
$2.67M
Total assets
$1.00B
Total debt
$559.32M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$59.49M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$10.55M
R&D / revenue
—
Stock compensation / revenue
8.5%

Ownership (13F)

9 metrics
13F filers
172
13F filer change QoQ
+9
Institutional ownership
81.1%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
17.1%
Private-fund adviser ownership
17.0%
Active holders' share change QoQ
+0.4%
Holder tenure
14.4
Price vs estimated holder cost
-8.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
28.6%

Short interest

3 metrics
Short interest
2.7%
Latest settlement · 2.2 days to cover
Days to cover
2.2d
Short-squeeze score
53 / 100

Insider activity

2 metrics
Net insider buying (90D)
$272,980
Insider-sentiment score
88 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1631569 CUSIP 20369C106 13F (30d) 29 filings 29 filers Visit website Investor relations